Trump will move to jumpstart FDA drug approval process

Published



President-elect Trump didn’t talk a lot about the Food and Drug Administration while he was on the campaign trail, but judging from what he did say, he will want the FDA to approve new drugs and products much faster.

However, experts and agency veterans say that Trump will get pushback from career staff at the FDA if he tries to go too far.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.